Clomiphene Citrate USP Active Pharmaceutical Ingredient Recalled for cGMP Deviations
Shimoga Chemicals is voluntarily recalling Clomiphene Citrate USP active pharmaceutical ingredient in three package sizes due to current good manufacturing practice (cGMP) deviations. The product was distributed in California and Florida.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing process deviations without reported illnesses or hospitalizations. The source text does not report any adverse health effects or injuries from this product, and cGMP deviations qualify as moderate-severity manufacturing concerns under the rubric.
Plain-English summary
Shimoga Chemicals is voluntarily recalling Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS 50-41-9) in three package sizes: 1 kg (NDC 84849-000-01), 500 g (NDC 84849-000-02), and 100 g (NDC 84849-000-03). The recall was initiated due to current good manufacturing practice (cGMP) deviations identified by the manufacturer.
The affected product was distributed in California and Florida. Multiple lots are included in this recall, with expiration dates ranging from August 2029 through January 2030.
The firm initiated this recall voluntarily on May 19, 2026, and notified the FDA by letter. The FDA classified this as a Class II recall on July 15, 2026. Healthcare professionals and organizations that received this product should stop distribution and contact Shimoga Chemicals regarding return or destruction of affected units.
The recalled product
- Product
- Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01), b) 500 g (NDC 84849-000-02), (c) 100 g (NDC 84849-000-03), Rx Only, Shimoga Chemicals Address -W-57A, MIDC Kupwad Samgli, Maharashtra, 416436, India.
- Manufacturer
- Shimoga Chemicals
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot #: a) CC/004/24-25
- Exp Date September 2029
- CC0032526
- Exp. Date August 2030 b) CC0442526
- Exp. Date Aug 2030
- CC/005/24-25
- Exp. Date November 2029 c) CC0032526
- Exp. Date August 2030
- CC/009/24-25
- Exp. Date January 2030
- Exp. Date November 2029.
Distribution
Distributed in 2 states:
- CA
- FL
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateGasco Isopropyl Alcohol 70% recalled for subpotent drug content
FDA (Drugs) · 2026-07-15
- ModerateGasco Isopropyl Alcohol 70% recalled nationwide for subpotency
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateDrogueria San Juan Isopropyl Alcohol 70% recalled for subpotency
FDA (Drugs) · 2026-07-15